Wednesday, December 31, 2014 4:37:24 PM
Recent CYTK News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 06:28:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 10:04:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 09:08:21 PM
- Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 09:00:00 PM
- Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089 • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:15 PM
- Cytokinetics Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/06/2024 09:00:00 PM
- Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024 • GlobeNewswire Inc. • 11/05/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 10:45:10 PM
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/04/2024 09:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:43:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 08:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 08:45:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/29/2024 08:08:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/28/2024 08:12:34 PM
- Cytokinetics to Announce Third Quarter Results on November 6, 2024 • GlobeNewswire Inc. • 10/23/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2024 10:45:28 PM
- Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day • GlobeNewswire Inc. • 10/16/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 08:32:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:00:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:08:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:28:19 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM